Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Promising preclinical results for FK-734 in preventing transplant rejection

Feb. 19, 2007

Sanofi pasteur licenses ChimeriVax-JE vaccine from Acambis

Feb. 16, 2007

RotaTeq prescribing information updated

Feb. 16, 2007

Positive preclinical results with a combined hepatitis A and E vaccine

Feb. 14, 2007

Novel cPLA2alpha inhibiting activity reported for the immunosuppressant agent FTY-720

Feb. 13, 2007

Pentavalent human-bovine rotavirus vaccine effective at end of shelf life

Feb. 9, 2007

New dosing recommendations for Rapamune in high immunologic risk patients

Feb. 7, 2007

Novel immunomodulatory agents disclosed in recent Kyorin and Novartis patents

Feb. 7, 2007

DelSite licenses technology to AriaVax for HIV vaccine

Feb. 6, 2007

End-of-phase II meeting for Pollinex Quattro Ragweed

Feb. 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...